Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
April 2026 Category 2 Update On April 15, 2026, the FDA confirmed removal of injectable GHK-Cu from Category 2 because the original nominations were withdrawn
Personalized Care Every treatment plan is tailored to your unique needs
OHIP does cover medical Botox for specific indications (chronic migraine, cervical dystonia, hyperhidrosis with documented failure of topical therapy) when administered by an authorized physician and pre-approved by the program
Its main role is to neutralize free radicals and detoxify cells
US$ 29.73
US$ 27.12
US$ 27.11
US$ 28.66
US$ 29.92
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 23.87
